reducing inappropriate implants among patients with severely reduced EF, and in identifying patients at higher arrhythmic risk among those with moderately reduced EF. In this study we investigated the relation between new promising parameters for arrhythmic risk evaluation, derived from I123-mIBG Scintigraphy (mIBG-S), and expressed in terms of early and late Heart/Mediastinum (eH/M and lH/M) and Wash-out Rate (WR), and a composite endpoint of arrhythmic events (AE) and SCD. Data derived from a prospective observational analyses on 29 patients eligible for primary-prevention ICD implantation, according to current ESC guidelines criteria, that underwent mIBG-S before the procedure. After a median follow-up of 24 months post-implantation, 20 patients presented AE, while only 2 patients had SCD. Statistically significant correlation was observed between mIBG-S markers and arrhythmic events to follow-up (eH/M: p=0,003, lH/M: p=0,001, WR: p=0,037), while only lH/M e WR (p=0,01 and p=0,038 respectively) showed significant correlation with SCD. Moreover, in the subgroup of patients (10) with EF between 30-35%, late H/M value <1,6 maintained statistically significant correlation with the composite endpoint, compared with EF (p=0,003 vs p=0,206). Even in a small sample, these results support the hypothesis of a prognostic and additive value of the evaluation of myocardial sympathetic innervation by mIBG-S for better arrhythmic risk stratification.
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The positive result of late potential after percutaneous coronary intervention for acute coronary syndromes may help the evaluation of the cardiovascular events Background: It is known that >60,000 people die of sudden cardiac death every year in japan. Among them, about 80% are caused by lifethreatening ventricular arrhythmias and a greater part of them based on ischemic cardiac disease. Objective: The aim of this study was to investigate the significance of late potential (LP) after percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS). Method: We enrolled 220 consecutive patients (177 male, 65±12.1 y/o) with ACS admitted to our University Hospital from January to December 2012. Twenty-four hour high-resolution ambulatory electrocardiogram was performed between post-PCI procedure and hospital discharge (8±0.5 days)). The 214 analyzable patients were divided into the LP-positive (n=43) and LP-negative (n=171) groups, and the relationship between LP and major adverse cardiovascular events (MACE; cardiogenic death, myocardial infarction [MI], re-hospitalization for unstable angina and chronic heart failure) was prospectively investigated. Patient's backgrounds were investigated as below; age, gender, coronary risk of hypertension / dyslipidemia / diabetes, past history of old MI and arrhythmia, additional medicine, brain natriuretic peptide and creatine phosphokinase on arrival, ejection fraction, culprit lesion, reperfusion time, and hospital days, creatinine and glomerular filtration rate. Results: There were no significance of patient's background in 14 variables except serum creatinine and glomerular filtration rate (GFR) on arrival. Proportion of MACE was 30.2% in the LP-positive group and 11.7% in the LP-negative group (p<0.01; by the Chi square test), and different between groups by the KaplanMaier analysis (p=0.01; 572±40.6 days). In the multivariable analysis with following variables (ejection fraction, creatine phosphokinase, creatinine and GFR), the odds ratio of positive LP for MACE was 3.3 (95% confidence interval, 1.4-7.6; p<0.01). Conclusion: Assessment of LP in ACS patients with PCI treatment may useful to predict the possible occurrence of MACE. Introduction: Brugada syndrome (BrS) patients (pts) with spontaneous type 1 electrocardiographic (ECG) pattern (sT1ECGp) have a greater arrhythmic risk compared to those with fleicainide-induced type 1 ECG pattern (iT1ECGp). However, when the analysis is restricted to asymptomatic pts, the type 1 spontaneous pattern loses its independent prognostic value. Late potentials (LP) obtained by signal-averaged ECG (SA-ECG) are associated with regions of delayed myocardial depolarization and consequent abnormal electrical conduction. There is a higher prevalence of LP obtained by SA-ECG in pts with BrS and their detection showed a strong prognostic predictor value in several studies. Objective: To evaluate the presence of LP by SA-ECG in pts with BrS and assess differences between patients with spontaneous or drug-induced type 1 ECG pattern. Methods: This was a single-center prospective study of consecutive pts diagnosed with BrS, including sT1ECGp and iT1ECGp. The patients were submitted to SA-ECG study to detect LP, with determination of the duration of filtered QRS (fQRS), root-mean-square voltage of the terminal 40ms of the filtered QRS (RMS40) and the duration of low-amplitude signal (<40 μV) in the terminal part of the filtered QRS complex (LAS40), using conventional and right modified leads. The presence of LP was considered positive when ≥2 of the following were present: fQRS ≥114 ms, RMS40 <20 μV or LAS40 ≥38ms. The results were displayed using medians and interquartile ranges, obtained using the Mann-Whitney test. Results: The presence of LP by SA-ECG was studied in 29 pts (75.9% male, mean age 44±12 years), 18 with sT1ECGp and 11 iT1ECGp. Only 3 pts (10.3%) had symptoms related with BrS (unexplained syncope) and none had documented malignant ventricular arrhythmias. Known or potential pathogenic mutations were identified in 5 pts (17.2%). The presence or absence of LP showed no statistically significant difference according to clinical, electrocardiographic or genetic characteristics of the pts. However, in conventional leads, pts with sT1ECGp showed significantly higher values of fQRS and lower values of RMS40 • complete coincidence (100% CI) in 75 patients (88.2%)
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• incomplete coincidence (75-99% CI) in 9 patients (10.6%)
• partial coincidence (50-75% CI)-none • low of coincidence degree (<50% CI) in 1 patient (1.2%) No episodes of PA dysfunction were registered.
Conclusion:
The results from our single centre study revealed that the portable tele-monitor PA is a highly reliable device for fast detection of various rhythm disorders in patients at high risk moved out the ICU in a step-down unit. The PA data reliability, when compared to Holter ECG, the qualities of the specialized "PatRis" software with a suitable user interface, database management, possibilities for remote control, and the acceptable price make it appropriate for routine use in cardiologuy practice.
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